UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000055793
Receipt number R000063266
Scientific Title A retrospective cohort study of elderly people with osteoporotic fractures: Sub analysis 1 (hip fractures and pelvic fractures)
Date of disclosure of the study information 2024/12/02
Last modified on 2026/02/25 12:00:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A retrospective cohort study of elderly people with osteoporotic fractures: Sub analysis 1 (hip fractures and pelvic fractures)

Acronym

A retrospective cohort study of elderly people with osteoporotic fractures: Sub analysis 1 (hip fractures and pelvic fractures)

Scientific Title

A retrospective cohort study of elderly people with osteoporotic fractures: Sub analysis 1 (hip fractures and pelvic fractures)

Scientific Title:Acronym

A retrospective cohort study of elderly people with osteoporotic fractures: Sub analysis 1 (hip fractures and pelvic fractures)

Region

Japan


Condition

Condition

osteoporosis

Classification by specialty

Geriatrics Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify the background and treatment status of elderly patients with osteoporotic fractures.

To clarify the intervention status and outcomes after osteoporotic hip and/or pelvic fractures.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

The occurrence of secondery fractures in patients with hip and/or pelvic fractures.

Key secondary outcomes

Mortality and other clinical outcomes in patients with hip and/or pelvic fractures.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

75 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.Patients with osteoporotic fractures

2.Subjects in the database between April 1, 2014 and March 31, 2025

3.Subjects aged 75 years or older

Key exclusion criteria

1.No data available after insurance enrollment.
2.Set for each analysis

Target sample size

1000000


Research contact person

Name of lead principal investigator

1st name Takahiko
Middle name
Last name Hamasaki

Organization

Japan Organization of Occupational Health and safety
Chugoku Rosai Hospital

Division name

Orthopedics

Zip code

737-0193

Address

1-5-1 Hirotagaya, Kure City, Hiroshima Pre.

TEL

0823-72-7171

Email

taka_ham@d3.dion.ne.jp


Public contact

Name of contact person

1st name Yoshiyuki
Middle name
Last name Saito

Organization

Datack, Inc.

Division name

none

Zip code

102-0072

Address

707, 1-8-9, Iidabashi Chiyoda-ku, Tokyo

TEL

080-1712-5964

Homepage URL


Email

info@datack.jp


Sponsor or person

Institute

J-BOLD Study Group

Institute

Department

Personal name



Funding Source

Organization

Asahi Kasei Pharma Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Asai Dermatology Institutional Review Board

Address

1-14 Tomoko-cho, Hodogaya-ku, Yokohama-shi, Kanagawa

Tel

03-5543-0196

Email

jimukyoku@smo-msr.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 12 Month 02 Day


Related information

URL releasing protocol

none

Publication of results

Unpublished


Result

URL related to results and publications

Results are not yet available due to an extended period of subjects in the database.

Number of participants that the trial has enrolled

1000000

Results

Results are not yet available as the period of subjects in the database has been extended.

Results date posted

2026 Year 02 Month 25 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Participant background information is not yet available due to the extended period of subjects in the database.

Participant flow

The flow of participants is still ongoing due to the extended period of subjects present in the database.

Adverse events

Adverse event results are still pending due to the extended duration of subjects present in the database.

Outcome measures

The study results have not yet been registered due to the extended period of subjects in the database.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2024 Year 08 Month 02 Day

Date of IRB

2026 Year 01 Month 19 Day

Anticipated trial start date

2024 Year 08 Month 20 Day

Last follow-up date

2027 Year 07 Month 31 Day

Date of closure to data entry

2027 Year 07 Month 31 Day

Date trial data considered complete

2027 Year 07 Month 31 Day

Date analysis concluded

2027 Year 10 Month 31 Day


Other

Other related information

None


Management information

Registered date

2024 Year 10 Month 09 Day

Last modified on

2026 Year 02 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063266